O2 is launching a pilot trial of a fully connected COVID-19 testing clinic-on-wheels, supported by O2’s 5G mobile network, which is designed to provide remote testing and tracking of care home residents and workers in Glasgow, as well as the delivery of essential medical supplies.
The University of Glasgow’s Adam Smith Business School and James Watt School of Engineering, and O2’s Darwin Innovation Group have been working in collaboration to create a proof-of-concept COVID-19 Connected Mobile Health Clinic (CMHC) that can be used in the trial.
Starting this summer, the trial will track COVID-19 at six care homes in Glasgow, capturing the data of 550 residents and care home workers over three months. The trial has been created to assess the area that one mobile testing unit can cover, in order to roll it out across the West of Scotland Region, where there are around 2.7 million patients that the mobile clinic could assist.
The CMHC will share the number of COVID-19 tests performed and the results to a secure cloud server via O2’s mobile network, which covers almost 99% of Scottish premises, 95% of which through 4G. The testing unit will then provide a dashboard of real-time epidemiological analysis to the NHS, the Scottish Government and public health organisations.
The project management team will also be able to track the vehicle’s position and behaviour and monitor the number of tests it’s carrying in its inventory to keep it running effectively.
The CMHC is designed to minimise exposure of care home residents and staff to COVID-19, thereby ensuring greater efficiency for healthcare workers and enhancing the testing capability of the NHS.
The project was created in response to an open request for help from the Scottish Government in March to fight COVID-19. With healthcare professionals currently overstretched, the CMHC aims to provide an innovative solution that factors in the distinctiveness of care homes in managing this outbreak.
The project will be used by the NHS to develop policy implementations and social business models to support its COVID-19 epidemic strategy. The scaled model will also be useful in future for remote diagnostics, health management and tele-consultation for the NHS, since vehicles will be equipped for both terrestrial and satellite communication, allowing for testing in the remotest areas of Scotland.
The project is co-funded by O2’s Darwin Innovation Group and the University of Glasgow’s EPSRC Impact Acceleration Account. It is part of Project Darwin, a four-year trial programme and partnership between O2 and the European Space Agency designed to develop and validate the next generation of connectivity solutions for connected and autonomous vehicles.
In March, O2 officially opened a new Darwin laboratory at the University of Glasgow alongside the European Space Agency. The laboratory is designed to develop proof of concepts for the next generation technology convergence needed for connected autonomous vehicles.
Derek McManus, Chief Operating Officer at O2 said:
“We’re delighted to be supporting this project with our 4G and 5G network to help the Scottish Government and NHS tackle and manage COVID-19. The Darwin laboratory in Glasgow was only officially opened at the start of this year and it’s exciting to be able to show so quickly how we can use innovations in 5G technology to unlock crucial solutions for society and revolutionise the way we use mobile connectivity.
“O2 is at the forefront of connectivity which is now one of the UK’s most valued services. As we look to rebuild Britain, we are constantly looking at how our customer-centric networks can help support this country.”
Professor Muhammad Imran, University of Glasgow James Watt School of Engineering added:
“The utility and scope of a mobile health clinic goes beyond this current pandemic. Engineering a fleet of connected healthcare response mobile units can provide services at the doorsteps of fragile and constrained patients all over the country even after the pandemic is over.”
